# Pilot Study of Haploidentical Donor Adenovirus Specific T-lymphocytes to Treat Refractory Adenovirus Infections

> **NCT04722029** · PHASE1,PHASE2 · RECRUITING · sponsor: **Nationwide Children's Hospital** · enrollment: 12 (estimated)

## Conditions studied

- Adenovirus Infection

## Interventions

- **BIOLOGICAL:** Adenovirus Specific T lymphocytes

## Key facts

- **NCT ID:** NCT04722029
- **Lead sponsor:** Nationwide Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-10-01
- **Primary completion:** 2026-10-01
- **Final completion:** 2027-10-01
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04722029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04722029, "Pilot Study of Haploidentical Donor Adenovirus Specific T-lymphocytes to Treat Refractory Adenovirus Infections". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04722029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*